ANI Pharmaceuticals, Inc. (ANIP)
72.29
+0.01
(+0.01%)
USD |
NASDAQ |
Oct 16, 16:00
72.25
-0.04
(-0.06%)
After-Hours: 20:00
ANI Pharmaceuticals Free Cash Flow (Quarterly) : 53.62M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.62M |
| March 31, 2026 | 47.05M |
| December 31, 2025 | 28.96M |
| September 30, 2025 | 37.89M |
| June 30, 2025 | 68.90M |
| March 31, 2025 | 15.14M |
| December 31, 2024 | 14.10M |
| September 30, 2024 | 7.031M |
| June 30, 2024 | 12.96M |
| March 31, 2024 | 13.69M |
| December 31, 2023 | 39.96M |
| September 30, 2023 | 27.62M |
| June 30, 2023 | 13.80M |
| March 31, 2023 | 19.07M |
| December 31, 2022 | -7.542M |
| September 30, 2022 | -6.191M |
| June 30, 2022 | -12.80M |
| March 31, 2022 | -21.12M |
| December 31, 2021 | -12.55M |
| September 30, 2021 | -5.985M |
| June 30, 2021 | -21.71M |
| March 31, 2021 | 19.93M |
| December 31, 2020 | -7.828M |
| September 30, 2020 | -7.423M |
| June 30, 2020 | 18.03M |
| Date | Value |
|---|---|
| March 31, 2020 | -55.84M |
| December 31, 2019 | 3.429M |
| September 30, 2019 | 19.86M |
| June 30, 2019 | 0.786M |
| March 31, 2019 | -5.994M |
| December 31, 2018 | 24.81M |
| September 30, 2018 | 6.794M |
| June 30, 2018 | 2.338M |
| March 31, 2018 | 20.65M |
| December 31, 2017 | -34.31M |
| September 30, 2017 | 14.60M |
| June 30, 2017 | -2.303M |
| March 31, 2017 | -46.56M |
| December 31, 2016 | 10.99M |
| September 30, 2016 | -0.005M |
| June 30, 2016 | -57.99M |
| March 31, 2016 | -74.58M |
| December 31, 2015 | 3.597M |
| September 30, 2015 | -16.53M |
| June 30, 2015 | 1.008M |
| March 31, 2015 | -3.492M |
| December 31, 2014 | 10.40M |
| September 30, 2014 | -18.37M |
| June 30, 2014 | 1.701M |
| March 31, 2014 | -7.456M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -70.64M |
| Liquidia Corp. | 69.01M |
| Elanco Animal Health, Inc. | 244.00M |
| Harmony Biosciences Holdings, Inc. | 92.43M |
| Corcept Therapeutics, Inc. | 31.02M |